Manufacturer: Sanofi Aventis manufactures ACOMPLIA.


The uses of ACOMPLIA include:
Appetite suppressant , Anti obesity drug. Acomplia is used complementary to diet and exercise to treat .obese or overweight patients who suffer from Type 2

diabetes and abnormal levels of fat in the blood

A single pill has been found to stop both food and cigarette cravings enough to help people quit smoking and lose weight, and could also help curb other unhealthy urges. In one study the medicine helped people who were overweight drop an average of 20 pounds and in another doubled the chances that smokers would quit. Acomplia contains the active ingredient Rimonabant. It is a selective CB1 Endocannabinoid Receptor Antagonist.

Acomplia works by blocking receptors of a substance called cannabinoid 1, which stimulates hunger and other cravings in the brain and is also present in fat tissue.

Sanofi argues that Acomplia can also prevent the risk of

Cardiovascular disease.

Patients with large waist circumference (102 cm in men and 88 cm

in women) will mostly benefit from taking the drug.

ACOMPLIA« (rimonabant) approved as an

adjunct to diet and exercise for the treatment of obese

patients (BMI ≥ 30 kg/m2), or overweight patients

(BMI > 27 kg/m2) with associated risk factors such as type 2

diabetes or dyslipidemia.

Side Effects:

Acomplia was said to be well tolerated in early tests. The only relatively common side effects were mild GI side effects and dizziness, and these were said to be transient.